Galantamine for treatment-resistant schizophrenia

Am J Psychiatry. 2002 Jul;159(7):1244-5. doi: 10.1176/appi.ajp.159.7.1244.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Agranulocytosis / chemically induced
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Cholinesterase Inhibitors / therapeutic use
  • Clozapine / adverse effects
  • Clozapine / therapeutic use
  • Drug Therapy, Combination
  • Galantamine / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Parasympathomimetics / therapeutic use*
  • Risperidone / therapeutic use
  • Schizophrenia / drug therapy*

Substances

  • Antipsychotic Agents
  • Cholinesterase Inhibitors
  • Parasympathomimetics
  • Galantamine
  • Clozapine
  • Risperidone